search
Back to results

Lipodystrophy and Fat Metabolism During Exercise (FAT)

Primary Purpose

Healthy, Lipodystrophy, Familial Partial

Status
Withdrawn
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
Caffeine
High-carbohdyrate breakfast
60-minutes of steady state exercise
Sponsored by
University of Exeter
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Healthy

Eligibility Criteria

18 Years - 35 Years (Adult)MaleAccepts Healthy Volunteers

SUBJECT WITH FPL

Inclusion:

• Already known to researchers. Male, 29 years old.

CONTROL SUBJECT 1

Inclusion:

  • Highly trained, elite-level cyclist (VO2max > 80 ml/kg/min)
  • Registered with, and racing under the jurisdiction of, British Cycling
  • ~< 10% of body fat
  • Male
  • 18 - 35 years old

Exclusion:

  • Any diagnosed metabolic impairment, as this may affect normal metabolism.
  • Any diagnosed cardiovascular disease or hypertension to avoid any complications associated with heavy exercise.
  • Chronic use of any prescribed or over-the-counter pharmaceuticals.

CONTROL SUBJECT 2

Inclusion:

  • Recreationally active, preferably with experience of cycling training.
  • Similar (± 5 ml⋅kg-1⋅min-1) VO2max¬ to that of the participant with MDP

Exclusion:

  • Any diagnosed metabolic impairment, as this may affect normal metabolism.
  • Any diagnosed cardiovascular disease or hypertension to avoid any complications associated with heavy exercise.
  • Chronic use of any prescribed or over-the-counter pharmaceuticals.

SUBJECT WITH FPL

Inclusion:

  • Recreationally active, preferably with experience of cycling training.
  • Similar (± 5 ml⋅kg-1⋅min-1) VO2max¬ to that of the participant with MDP
  • Diagnosis with FPL

Exclusion:

  • Female
  • Any diagnosed cardiovascular disease or hypertension to avoid any complications associated with heavy exercise.

Sites / Locations

  • School of Sport and Health Sciences

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Experimental

Experimental

Arm Label

Exercising following the ingestion of a high-carbohydrate br

Exercising following the ingestion of caffeine only

Exercising in the absence of breakfast or caffeine ingestion

Arm Description

60 minutes of cycling, with the ingestion of a high-carbohydrate breakfast and 200 mg of caffeine.

60 minutes of cycling, with the ingestion of 200 mg of caffeine.

60 minutes of cycling, without the ingestion of breakfast, or caffeine.

Outcomes

Primary Outcome Measures

Substrate utilisation
n..b. Please be aware that the below is a single, composite measure, wherein no single outcome measure cannot exist without the other. As such, it is presented as is, below. How carbohydrate and caffeine ingestion can affect the contribution to energy expenditure during 1 hour of exercise at 55%Wmax from: Plasma free fatty acids Plasma glucose Muscle glycogen Fat from other sources (predominantly muscle) This will be calculated from Plasma free fatty acid oxidation: Production of breath 13CO2 from a continuous infusion of [U-13C]palmitate Plasma glucose oxidation: The rate of disappearance of labelled [6, 6-2H2] glucose from a continuous infusion Muscle glycogen = Total carbohydrate oxidation - plasma glucose oxidation Fat from other sources = total fat oxidation - plasma free fatty acid oxidation

Secondary Outcome Measures

Heart rate
Heart rate will be measured throughout with the use of a heart rate monitor.
Plasma glucose concentrations
A cannula will be used to draw blood from subjects at several time points. Whole blood samples will be analysed immediately for plasma glucose.
Plasma lactate concentrations
A cannula will be used to draw blood from subjects at several time points. Whole blood samples will be analysed immediately for plasma lactate.
Plasma NEFA concentrations
A cannula will be used to draw blood from subjects at several time points. At the end of the trial, plasma samples will be moved to a -80°C freezer for later analysis for NEFA.

Full Information

First Posted
May 23, 2019
Last Updated
August 25, 2021
Sponsor
University of Exeter
search

1. Study Identification

Unique Protocol Identification Number
NCT04056000
Brief Title
Lipodystrophy and Fat Metabolism During Exercise
Acronym
FAT
Official Title
The Regulation of Fat Metabolism in a Cyclist With Lipodystrophy: a Case Study
Study Type
Interventional

2. Study Status

Record Verification Date
August 2021
Overall Recruitment Status
Withdrawn
Why Stopped
ethical and governance issues not resolved
Study Start Date
September 1, 2019 (Anticipated)
Primary Completion Date
December 31, 2019 (Anticipated)
Study Completion Date
December 31, 2019 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Exeter

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Mandibular dysplasia with deafness and progeroid features (MDP) syndrome is a rare genetic metabolic disorder that causes lipodystrophy: the inability of the body to store subcutaneous adipose tissue (fat under the skin). This creates a unique scenario where any ingested fat is diverted to the abdomen and liver, often leading to diabetes. The investigators have an opportunity to study an individual with MDP who has competed in and won national para-cycling championships and is able to prevent/control his diabetes by regular bicycle training. He has approached us for advice on nutritional strategies to improve his cycling performance, and insight into how he uses fat during exercise. The investigators also wish to study a moderately-trained cyclist with Familial partial lipodystrophy (FPL). Those with FPL show a different pattern of lipodystrophy than those with MDP, allowing us to further increase the investigator's understanding of fat utilisation in those with lipodystrophy during exercise. The investigators know how subcutaneous fat is used during exercise, and how duration, nutrition, carbohydrate availability, and exercise intensity can affect this. The investigators aim to investigate these processes during exercise in MDP and FPL. This will potentially provide nutrition and performance advice to the individuals, and insight on fat use in lipodystrophy and diabetes.
Detailed Description
During prolonged sub-maximal endurance exercise, both fat and carbohydrate are readily used substrates. The relative contribution and regulation of either is dependent on substrate availability (endogenous and exogenous), the duration of exercise, and the intensity of exercise. For example, exercising under fasted or caffeine supplemented conditions increases adipose tissue lipolysis, free fatty acid availability, and thus fat utilisation, whilst exercising under fed or carbohydrate loaded conditions increases glucose availability from elevated liver and muscle glycogen stores, and thus carbohydrate utilisation. This is important during prolonged sub-maximal exercise because when the limited endogenous carbohydrate stores are depleted, the body must rely more on fat. However, it is not known whether this regulation is present in conditions such as MDP and FPL where there is essentially no adipose tissue. The investigators have an opportunity to study an individual with MDP who has competed in and won national para-cycling championships. He has approached us for advice on nutritional strategies to improve his cycling performance, and insight into how he uses fat during exercise. Intriguingly, the individual has provided anecdotal evidence that exercising under fasted conditions severely impairs his performance but that the use of caffeine improves his performance. He also states that he uses carbohydrate feeding strategies before and during prolonged exercise but is unsure whether it helps or not. This raises two fundamental questions that should be answered before any nutritional advice should be given (e.g. should a pre-exercise fat feeding or low glycemic index carbohydrate strategy be adopted?): Do fasting and caffeine stimulate lipolysis in lipodystrophy and, if so, where is the fat coming from? Does carbohydrate feeding before exercise impair lipolysis in lipodystrophy? In order to answer these questions, the investigators need to directly measure rates of fat and carbohydrate utilisation from the circulation and muscle stores during exercise in the individual and a control participant using a stable isotope infusion approach. As well as providing results of significant scientific interest to the lipodystrophy field (researchers, clinicians, patients) and answering fundamental exercise physiology questions on substrate availability, the investigators hope that the outcomes will offer a substantial platform for improving the participant's knowledge of exercise nutrition and exercise performance.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Healthy, Lipodystrophy, Familial Partial

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
0 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Exercising following the ingestion of a high-carbohydrate br
Arm Type
Experimental
Arm Description
60 minutes of cycling, with the ingestion of a high-carbohydrate breakfast and 200 mg of caffeine.
Arm Title
Exercising following the ingestion of caffeine only
Arm Type
Experimental
Arm Description
60 minutes of cycling, with the ingestion of 200 mg of caffeine.
Arm Title
Exercising in the absence of breakfast or caffeine ingestion
Arm Type
Experimental
Arm Description
60 minutes of cycling, without the ingestion of breakfast, or caffeine.
Intervention Type
Dietary Supplement
Intervention Name(s)
Caffeine
Intervention Description
200 mg of caffeine, 60 minutes before exercise
Intervention Type
Dietary Supplement
Intervention Name(s)
High-carbohdyrate breakfast
Intervention Description
Ingestion of a high-carbohydrate breakfast 60 minutes before exercise
Intervention Type
Behavioral
Intervention Name(s)
60-minutes of steady state exercise
Intervention Description
See intervention name
Primary Outcome Measure Information:
Title
Substrate utilisation
Description
n..b. Please be aware that the below is a single, composite measure, wherein no single outcome measure cannot exist without the other. As such, it is presented as is, below. How carbohydrate and caffeine ingestion can affect the contribution to energy expenditure during 1 hour of exercise at 55%Wmax from: Plasma free fatty acids Plasma glucose Muscle glycogen Fat from other sources (predominantly muscle) This will be calculated from Plasma free fatty acid oxidation: Production of breath 13CO2 from a continuous infusion of [U-13C]palmitate Plasma glucose oxidation: The rate of disappearance of labelled [6, 6-2H2] glucose from a continuous infusion Muscle glycogen = Total carbohydrate oxidation - plasma glucose oxidation Fat from other sources = total fat oxidation - plasma free fatty acid oxidation
Time Frame
Throughout the 60 minute cycle
Secondary Outcome Measure Information:
Title
Heart rate
Description
Heart rate will be measured throughout with the use of a heart rate monitor.
Time Frame
Throughout the 60 minute cycle
Title
Plasma glucose concentrations
Description
A cannula will be used to draw blood from subjects at several time points. Whole blood samples will be analysed immediately for plasma glucose.
Time Frame
Throughout the 60 minute cycle
Title
Plasma lactate concentrations
Description
A cannula will be used to draw blood from subjects at several time points. Whole blood samples will be analysed immediately for plasma lactate.
Time Frame
Throughout the 60 minute cycle
Title
Plasma NEFA concentrations
Description
A cannula will be used to draw blood from subjects at several time points. At the end of the trial, plasma samples will be moved to a -80°C freezer for later analysis for NEFA.
Time Frame
Throughout the 60 minute cycle

10. Eligibility

Sex
Male
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
35 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
SUBJECT WITH FPL Inclusion: • Already known to researchers. Male, 29 years old. CONTROL SUBJECT 1 Inclusion: Highly trained, elite-level cyclist (VO2max > 80 ml/kg/min) Registered with, and racing under the jurisdiction of, British Cycling ~< 10% of body fat Male 18 - 35 years old Exclusion: Any diagnosed metabolic impairment, as this may affect normal metabolism. Any diagnosed cardiovascular disease or hypertension to avoid any complications associated with heavy exercise. Chronic use of any prescribed or over-the-counter pharmaceuticals. CONTROL SUBJECT 2 Inclusion: Recreationally active, preferably with experience of cycling training. Similar (± 5 ml⋅kg-1⋅min-1) VO2max¬ to that of the participant with MDP Exclusion: Any diagnosed metabolic impairment, as this may affect normal metabolism. Any diagnosed cardiovascular disease or hypertension to avoid any complications associated with heavy exercise. Chronic use of any prescribed or over-the-counter pharmaceuticals. SUBJECT WITH FPL Inclusion: Recreationally active, preferably with experience of cycling training. Similar (± 5 ml⋅kg-1⋅min-1) VO2max¬ to that of the participant with MDP Diagnosis with FPL Exclusion: Female Any diagnosed cardiovascular disease or hypertension to avoid any complications associated with heavy exercise.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Andrew Davenport, MSc
Organizational Affiliation
The University of Exeter
Official's Role
Principal Investigator
Facility Information:
Facility Name
School of Sport and Health Sciences
City
Exeter
State/Province
Devon
ZIP/Postal Code
EX4 4JA
Country
United Kingdom

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Lipodystrophy and Fat Metabolism During Exercise

We'll reach out to this number within 24 hrs